152 related articles for article (PubMed ID: 1663781)
21. [Hereditary gastrointestinal neoplasias].
Fendrich V; Bartsch DK
Z Gastroenterol; 2005 Feb; 43(2):219-25. PubMed ID: 15700217
[TBL] [Abstract][Full Text] [Related]
22. Loss of constitutional heterozygosity in colorectal tumors from patients with familial polyposis coli and those with nonpolyposis colorectal carcinoma.
Sasaki M; Okamoto M; Sato C; Sugio K; Soejima J; Iwama T; Ikeuchi T; Tonomura A; Miyaki M; Sasazuki T
Cancer Res; 1989 Aug; 49(16):4402-6. PubMed ID: 2568169
[TBL] [Abstract][Full Text] [Related]
23. Chromosome 5 allele loss in human colorectal carcinomas.
Solomon E; Voss R; Hall V; Bodmer WF; Jass JR; Jeffreys AJ; Lucibello FC; Patel I; Rider SH
Nature; 1987 Aug 13-19; 328(6131):616-9. PubMed ID: 2886919
[TBL] [Abstract][Full Text] [Related]
24. The adenomatous polyposis coli gene and human cancers.
Nakamura Y
J Cancer Res Clin Oncol; 1995; 121(9-10):529-34. PubMed ID: 7559732
[TBL] [Abstract][Full Text] [Related]
25. Loss of heterozygosity involving the APC and MCC genetic loci occurs in the majority of human esophageal cancers.
Boynton RF; Blount PL; Yin J; Brown VL; Huang Y; Tong Y; McDaniel T; Newkirk C; Resau JH; Raskind WH; Haggitt RC; Reid BJ; Meltzer SJ
Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3385-8. PubMed ID: 1565631
[TBL] [Abstract][Full Text] [Related]
26. ITF-2 is disrupted via allelic loss of chromosome 18q21, and ITF-2B expression is lost at the adenoma-carcinoma transition.
Herbst A; Bommer GT; Kriegl L; Jung A; Behrens A; Csanadi E; Gerhard M; Bolz C; Riesenberg R; Zimmermann W; Dietmaier W; Wolf I; Brabletz T; Göke B; Kolligs FT
Gastroenterology; 2009 Aug; 137(2):639-48, 648.e1-9. PubMed ID: 19394332
[TBL] [Abstract][Full Text] [Related]
27. K-ras mutations in the duodenal fluid of patients with pancreatic carcinoma.
Wilentz RE; Chung CH; Sturm PD; Musler A; Sohn TA; Offerhaus GJ; Yeo CJ; Hruban RH; Slebos RJ
Cancer; 1998 Jan; 82(1):96-103. PubMed ID: 9428484
[TBL] [Abstract][Full Text] [Related]
28. No duplicate KRAS mutation is identified on the same allele in gastric or colorectal cancer cells with multiple KRAS mutations.
Kimura K; Nagasaka T; Hoshizima N; Sasamoto H; Notohara K; Takeda M; Kominami K; Iishii T; Tanaka N; Matsubara N
J Int Med Res; 2007; 35(4):450-7. PubMed ID: 17697521
[TBL] [Abstract][Full Text] [Related]
29. MCC, a candidate familial polyposis gene in 5q.21, shows frequent allele loss in colorectal and lung cancer.
Ashton-Rickardt PG; Wyllie AH; Bird CC; Dunlop MG; Steel CM; Morris RG; Piris J; Romanowski P; Wood R; White R
Oncogene; 1991 Oct; 6(10):1881-6. PubMed ID: 1656365
[TBL] [Abstract][Full Text] [Related]
30. A study of chromosome 6 allele loss in human colorectal carcinomas.
Wildrick DM; Alfaro SR; Gope R; Boman BM
Anticancer Res; 1992; 12(5):1717-9. PubMed ID: 1332582
[TBL] [Abstract][Full Text] [Related]
31. Two distinct regions of deletion on the long arm of chromosome 5 in differentiated adenocarcinomas of the stomach.
Tamura G; Ogasawara S; Nishizuka S; Sakata K; Maesawa C; Suzuki Y; Terashima M; Saito K; Satodate R
Cancer Res; 1996 Feb; 56(3):612-5. PubMed ID: 8564980
[TBL] [Abstract][Full Text] [Related]
32. Loss of heterozygosity of APC/MCC gene in differentiated and undifferentiated gastric carcinomas in Taiwan.
Hsieh LL; Huang YC
Cancer Lett; 1995 Sep; 96(2):169-74. PubMed ID: 7585453
[TBL] [Abstract][Full Text] [Related]
33. Multiple genetic alterations in distal and proximal colorectal cancer.
Delattre O; Olschwang S; Law DJ; Melot T; Remvikos Y; Salmon RJ; Sastre X; Validire P; Feinberg AP; Thomas G
Lancet; 1989 Aug; 2(8659):353-6. PubMed ID: 2569552
[TBL] [Abstract][Full Text] [Related]
34. Inactivation of both alleles of the DPC4/SMAD4 gene in advanced colorectal cancers: identification of seven novel somatic mutations in tumors from Japanese patients.
Koyama M; Ito M; Nagai H; Emi M; Moriyama Y
Mutat Res; 1999 Aug; 406(2-4):71-7. PubMed ID: 10479724
[TBL] [Abstract][Full Text] [Related]
35. Stability of critical genetic lesions in human colorectal carcinoma xenografts.
McQueen HA; Wyllie AH; Piris J; Foster E; Bird CC
Br J Cancer; 1991 Jan; 63(1):94-6. PubMed ID: 1989671
[No Abstract] [Full Text] [Related]
36. Recurrent deletions involving chromosomes 1, 5, 17, and 18 in colorectal carcinoma: possible role in biological and clinical behavior of tumors.
Gerdes H; Chen Q; Elahi AH; Sircar A; Goldberg E; Winawer D; Urmacher C; Winawer SJ; Jhanwar SC
Anticancer Res; 1995; 15(1):13-24. PubMed ID: 7733622
[TBL] [Abstract][Full Text] [Related]
37. Chromosome 5 allele loss in familial and sporadic colorectal adenomas.
Rees M; Leigh SE; Delhanty JD; Jass JR
Br J Cancer; 1989 Mar; 59(3):361-5. PubMed ID: 2539177
[TBL] [Abstract][Full Text] [Related]
38. Molecular pathogenesis of adenoma and differentiated adenocarcinoma of the stomach.
Tamura G
Pathol Int; 1996 Nov; 46(11):834-41. PubMed ID: 8970192
[TBL] [Abstract][Full Text] [Related]
39. Decreased expression of DCC mRNA in gastric and colorectal cancer.
Kataoka M; Okabayashi T; Orita K
Surg Today; 1995; 25(12):1001-7. PubMed ID: 8645930
[TBL] [Abstract][Full Text] [Related]
40. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients.
Nishisho I; Nakamura Y; Miyoshi Y; Miki Y; Ando H; Horii A; Koyama K; Utsunomiya J; Baba S; Hedge P
Science; 1991 Aug; 253(5020):665-9. PubMed ID: 1651563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
